The work also demonstrated that CD98, β1-integrin-A and Ki-67 were upregulated in HCC tissues, and the concomitant expression of these three biomarkers was associated with clinical pathological characteristics of HCC patients including tumor size and tumor stage. Here, SLC3A2 is linked to hepatocellular carcinoma.